FDA advisory committee will vote on Thursday to release the Pfizer-BioNTech COVID-19 vaccine

Food and Drug Administration (FDA) 15-person advisory committee indicated its initial review of the Pfizer-BioNTech vaccine's effectiveness was "highly" positive